What is the recommended dosage and usage of Flexeril (cyclobenzaprine) for treating muscle spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage and Usage of Cyclobenzaprine (Flexeril) for Muscle Spasms

For most patients, the recommended dosage of cyclobenzaprine is 5 mg three times daily, which may be increased to 10 mg three times daily based on individual response. 1

Standard Dosing Regimen

  • The FDA-approved dosage for cyclobenzaprine is 5 mg three times daily, which can be increased to 10 mg three times daily if needed 1
  • Treatment duration should not exceed two to three weeks, as longer use is not recommended 1
  • Lower doses (5 mg TID) are as effective as higher doses (10 mg TID) with fewer sedative side effects 2

Special Populations

  • Elderly patients should receive less frequent dosing due to increased risk of adverse effects 1
  • Patients with mild hepatic impairment should start with 5 mg and titrate slowly upward 1
  • Cyclobenzaprine is not recommended for patients with moderate to severe hepatic impairment 1
  • The American Geriatrics Society identifies cyclobenzaprine as potentially inappropriate for older adults due to increased risk of anticholinergic effects, sedation, and falls 3

Efficacy Evidence

  • Cyclobenzaprine has been shown to be moderately superior to placebo for short-term (2-4 days) pain relief in acute low back pain 4
  • Onset of relief is typically apparent within 3-4 doses of the 5 mg regimen 2
  • For chronic low back pain, evidence is limited, with only one lower-quality trial that did not report pain intensity or global efficacy 4
  • Extended-release formulations (15 mg and 30 mg once daily) have shown effectiveness comparable to immediate-release formulations with potentially less daytime drowsiness 5, 6

Side Effects and Monitoring

  • Most common adverse effects are drowsiness (dose-related) and dry mouth 2
  • Central nervous system adverse events (drowsiness, dizziness, fatigue) occur more frequently with cyclobenzaprine than with placebo 4
  • Monitor for signs of serotonin syndrome when used with other serotonergic medications 3
  • Consider the cumulative anticholinergic burden when prescribing to patients on other anticholinergic medications 3

Comparative Efficacy

  • No significant difference in efficacy between cyclobenzaprine monotherapy (5 mg TID) and combination therapy with ibuprofen for acute neck or back pain with muscle spasm 7
  • Cyclobenzaprine shows similar efficacy to diazepam for muscle spasm, but with different side effect profiles (more dry mouth with cyclobenzaprine, more dizziness with diazepam) 4, 8
  • There is insufficient evidence to conclude that any specific muscle relaxant is superior to others for benefits or harms 4

Important Considerations

  • Cyclobenzaprine is structurally similar to tricyclic antidepressants and shares their potential adverse effects 4
  • Cyclobenzaprine should be held on the day of surgery due to potential interactions with anesthetics 3
  • When discontinuing after long-term use, gradual tapering over 2-3 weeks is recommended to avoid withdrawal symptoms 3
  • Efficacy appears to be independent of sedation, as significant treatment effects were observed in patients who did not report somnolence 2

Remember that cyclobenzaprine is intended for short-term use only (2-3 weeks maximum) as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.